These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 31659695)

  • 1. Comprehensive bioinformatics study reveals targets and molecular mechanism of hesperetin in overcoming breast cancer chemoresistance.
    Hermawan A; Putri H; Utomo RY
    Mol Divers; 2020 Nov; 24(4):933-947. PubMed ID: 31659695
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Integrative Bioinformatics Analysis Reveals Potential Target Genes and TNFα Signaling Inhibition by Brazilin in Metastatic Breast Cancer Cells.
    Hermawan A; Putri H
    Asian Pac J Cancer Prev; 2020 Sep; 21(9):2751-2762. PubMed ID: 32986377
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systematic analysis of gene expression pattern in has-miR-760 overexpressed resistance of the MCF-7 human breast cancer cell to doxorubicin.
    Lv J; Fu Z; Shi M; Xia K; Ji C; Xu P; Lv M; Pan B; Dai L; Xie H
    Biomed Pharmacother; 2015 Feb; 69():162-9. PubMed ID: 25661353
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bioinformatic identification of chemoresistance-associated microRNAs in breast cancer based on microarray data.
    Wang YW; Zhang W; Ma R
    Oncol Rep; 2018 Mar; 39(3):1003-1010. PubMed ID: 29328395
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MDM2 is a Potential Target Gene of Glycyrrhizic Acid for Circumventing Breast Cancer Resistance to Tamoxifen: Integrative Bioinformatics Analysis.
    Azzahra SNA; Hanif N; Hermawan A
    Asian Pac J Cancer Prev; 2022 Jul; 23(7):2341-2350. PubMed ID: 35901340
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hesperetin and Naringenin sensitize HER2 positive cancer cells to death by serving as HER2 Tyrosine Kinase inhibitors.
    Chandrika BB; Steephan M; Kumar TRS; Sabu A; Haridas M
    Life Sci; 2016 Sep; 160():47-56. PubMed ID: 27449398
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hesperetin reverses P‑glycoprotein‑mediated cisplatin resistance in DDP‑resistant human lung cancer cells via modulation of the nuclear factor‑κB signaling pathway.
    Kong W; Ling X; Chen Y; Wu X; Zhao Z; Wang W; Wang S; Lai G; Yu Z
    Int J Mol Med; 2020 Apr; 45(4):1213-1224. PubMed ID: 32124932
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of key genes of hesperidin in inhibition of breast cancer stem cells by functional network analysis.
    Hermawan A; Khumaira A; Ikawati M; Putri H; Jenie RI; Angraini SM; Muflikhasari HA
    Comput Biol Chem; 2021 Feb; 90():107427. PubMed ID: 33360419
    [TBL] [Abstract][Full Text] [Related]  

  • 9. miRNA expression patterns in chemoresistant breast cancer tissues.
    Lv J; Xia K; Xu P; Sun E; Ma J; Gao S; Zhou Q; Zhang M; Wang F; Chen F; Zhou P; Fu Z; Xie H
    Biomed Pharmacother; 2014 Oct; 68(8):935-42. PubMed ID: 25451164
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genomic Understanding Reveals the Important Role of FGFR2 as Paeoniflorin Target for Circumventing Breast Cancer Resistance to Tamoxifen.
    Wibowo MA; Nugroho EP; Hermawan A
    Asian Pac J Cancer Prev; 2021 Dec; 22(12):3949-3958. PubMed ID: 34967576
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The 3D genomic landscape of differential response to EGFR/HER2 inhibition in endocrine-resistant breast cancer cells.
    Yang Y; Choppavarapu L; Fang K; Naeini AS; Nosirov B; Li J; Yang K; He Z; Zhou Y; Schiff R; Li R; Hu Y; Wang J; Jin VX
    Biochim Biophys Acta Gene Regul Mech; 2020 Nov; 1863(11):194631. PubMed ID: 32956836
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Survivin-targeting miR-542-3p overcomes HER3 signaling-induced chemoresistance and enhances the antitumor activity of paclitaxel against HER2-overexpressing breast cancer.
    Lyu H; Wang S; Huang J; Wang B; He Z; Liu B
    Cancer Lett; 2018 Apr; 420():97-108. PubMed ID: 29409974
    [TBL] [Abstract][Full Text] [Related]  

  • 13. GSK-3 inhibition overcomes chemoresistance in human breast cancer.
    Ugolkov A; Gaisina I; Zhang JS; Billadeau DD; White K; Kozikowski A; Jain S; Cristofanilli M; Giles F; O'Halloran T; Cryns VL; Mazar AP
    Cancer Lett; 2016 Oct; 380(2):384-392. PubMed ID: 27424289
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The pleiotropic effects of fisetin and hesperetin on human acute promyelocytic leukemia cells are mediated through apoptosis, cell cycle arrest, and alterations in signaling networks.
    Adan A; Baran Y
    Tumour Biol; 2015 Nov; 36(11):8973-84. PubMed ID: 26081618
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Topological network analysis of differentially expressed genes in cancer cells with acquired gefitinib resistance.
    Lee YS; Hwang SG; Kim JK; Park TH; Kim YR; Myeong HS; Kwon K; Jang CS; Noh YH; Kim SY
    Cancer Genomics Proteomics; 2015; 12(3):153-66. PubMed ID: 25977174
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fisetin and hesperetin induced apoptosis and cell cycle arrest in chronic myeloid leukemia cells accompanied by modulation of cellular signaling.
    Adan A; Baran Y
    Tumour Biol; 2016 May; 37(5):5781-95. PubMed ID: 26408178
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identifying differentially expressed genes and screening small molecule drugs for lapatinib-resistance of breast cancer by a bioinformatics strategy.
    Zhuo WL; Zhang L; Xie QC; Zhu B; Chen ZT
    Asian Pac J Cancer Prev; 2014; 15(24):10847-53. PubMed ID: 25605188
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemotherapy-driven increases in the CDKN1A/PTN/PTPRZ1 axis promote chemoresistance by activating the NF-κB pathway in breast cancer cells.
    Huang P; Ouyang DJ; Chang S; Li MY; Li L; Li QY; Zeng R; Zou QY; Su J; Zhao P; Pei L; Yi WJ
    Cell Commun Signal; 2018 Nov; 16(1):92. PubMed ID: 30497491
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FGFR4 Links Glucose Metabolism and Chemotherapy Resistance in Breast Cancer.
    Xu M; Chen S; Yang W; Cheng X; Ye Y; Mao J; Wu X; Huang L; Ji J
    Cell Physiol Biochem; 2018; 47(1):151-160. PubMed ID: 29763898
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overcoming acquired resistance to HSP90 inhibition by targeting JAK-STAT signalling in triple-negative breast cancer.
    Mumin NH; Drobnitzky N; Patel A; Lourenco LM; Cahill FF; Jiang Y; Kong A; Ryan AJ
    BMC Cancer; 2019 Jan; 19(1):102. PubMed ID: 30678647
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.